iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gained analyst confidence with higher price targets.
Latest Ratings for IRTC
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022NeedhamUpgradesHoldBuy Jan 2022JP MorganMaintainsOverweight